PARP1 抗体
(Poly (ADP-Ribose) Polymerase 1 (PARP1))
This gene encodes a chromatin-associated enzyme, poly(ADP-ribosyl)transferase, which modifies various nuclear proteins by poly(ADP-ribosyl)ation. The modification is dependent on DNA and is involved in the regulation of various important cellular processes such as differentiation, proliferation, and tumor transformation and also in the regulation of the molecular events involved in the recovery of cell from DNA damage. In addition, this enzyme may be the site of mutation in Fanconi anemia, and may participate in the pathophysiology of type I diabetes. [provided by RefSeq, Jul 2008].
Recommended next Filters:
361 results
PARP1
适用: 人
WB, IF (p), IF (cc)
宿主: 兔
Polyclonal
AbBy Fluor® 750
PARP1
适用: 人
WB, IF (p), IF (cc)
宿主: 兔
Polyclonal
AbBy Fluor® 680
PARP1
适用: 人
WB, IF (p), IF (cc)
宿主: 兔
Polyclonal
AbBy Fluor® 647
PARP1
适用: 人
WB, IF (p), IF (cc)
宿主: 兔
Polyclonal
AbBy Fluor® 555
PARP1
适用: 人
WB, IF (p), IF (cc)
宿主: 兔
Polyclonal
AbBy Fluor® 488
Latest Publications for our PARP1 抗体
: "Enhancing the antitumor activity of an engineered TRAIL-coated oncolytic adenovirus for treating acute myeloid leukemia." in: Signal transduction and targeted therapy, Vol. 5, Issue 1, pp. 40, (2020) (PubMed).
: "Biological effects of whole Z.Officinale extract on chronic myeloid leukemia cell line K562." in: Gene, Vol. 692, pp. 217-222, (2019) (PubMed).
: "The inhibition of Bax activation-induced apoptosis by RasGRP2 via R-Ras-PI3K-Akt signaling pathway in the endothelial cells." in: Scientific reports, Vol. 9, Issue 1, pp. 16717, (2019) (PubMed).
: "Genetic and Epigenetic Perturbations by DNMT3A-R882 Mutants Impaired Apoptosis through Augmentation of PRDX2 in Myeloid Leukemia Cells." in: Neoplasia (New York, N.Y.), Vol. 20, Issue 11, pp. 1106-1120, (2019) (PubMed).
: "Neuronal sphingosine kinase 2 subcellular localization is altered in Alzheimer's disease brain." in: Acta neuropathologica communications, Vol. 6, Issue 1, pp. 25, (2019) (PubMed).
: "Upregulation of CISD2 augments ROS homeostasis and contributes to tumorigenesis and poor prognosis of lung adenocarcinoma." in: Scientific reports, Vol. 7, Issue 1, pp. 11893, (2019) (PubMed).
: "Oligo-Porphyran Ameliorates Neurobehavioral Deficits in Parkinsonian Mice by Regulating the PI3K/Akt/Bcl-2 Pathway." in: Marine drugs, Vol. 16, Issue 3, (2018) (PubMed).
: "Glutathione disulfide sensitizes hepatocytes to TNFα-mediated cytotoxicity via IKK-β S-glutathionylation: a potential mechanism underlying non-alcoholic fatty liver disease." in: Experimental & molecular medicine, Vol. 50, Issue 4, pp. 7, (2018) (PubMed).
: "Epigallocatechin-3-Gallate Ameliorates Glucocorticoid-Induced Osteoporosis of Rats in Vivo and in Vitro." in: Frontiers in pharmacology, Vol. 9, pp. 447, (2018) (PubMed).
: "NVP-BEZ235 synergizes cisplatin sensitivity in osteosarcoma." in: Oncotarget, Vol. 9, Issue 12, pp. 10483-10496, (2018) (PubMed).
: "Biological effects of whole Z.Officinale extract on chronic myeloid leukemia cell line K562." in: Gene, Vol. 692, pp. 217-222, (2019) (PubMed).
: "The inhibition of Bax activation-induced apoptosis by RasGRP2 via R-Ras-PI3K-Akt signaling pathway in the endothelial cells." in: Scientific reports, Vol. 9, Issue 1, pp. 16717, (2019) (PubMed).
: "Genetic and Epigenetic Perturbations by DNMT3A-R882 Mutants Impaired Apoptosis through Augmentation of PRDX2 in Myeloid Leukemia Cells." in: Neoplasia (New York, N.Y.), Vol. 20, Issue 11, pp. 1106-1120, (2019) (PubMed).
: "Neuronal sphingosine kinase 2 subcellular localization is altered in Alzheimer's disease brain." in: Acta neuropathologica communications, Vol. 6, Issue 1, pp. 25, (2019) (PubMed).
: "Upregulation of CISD2 augments ROS homeostasis and contributes to tumorigenesis and poor prognosis of lung adenocarcinoma." in: Scientific reports, Vol. 7, Issue 1, pp. 11893, (2019) (PubMed).
: "Oligo-Porphyran Ameliorates Neurobehavioral Deficits in Parkinsonian Mice by Regulating the PI3K/Akt/Bcl-2 Pathway." in: Marine drugs, Vol. 16, Issue 3, (2018) (PubMed).
: "Glutathione disulfide sensitizes hepatocytes to TNFα-mediated cytotoxicity via IKK-β S-glutathionylation: a potential mechanism underlying non-alcoholic fatty liver disease." in: Experimental & molecular medicine, Vol. 50, Issue 4, pp. 7, (2018) (PubMed).
: "Epigallocatechin-3-Gallate Ameliorates Glucocorticoid-Induced Osteoporosis of Rats in Vivo and in Vitro." in: Frontiers in pharmacology, Vol. 9, pp. 447, (2018) (PubMed).
: "NVP-BEZ235 synergizes cisplatin sensitivity in osteosarcoma." in: Oncotarget, Vol. 9, Issue 12, pp. 10483-10496, (2018) (PubMed).
Aliases for PARP1 抗体
poly(ADP-ribose) polymerase 1 (PARP1) 抗体poly (ADP-ribose) polymerase 1 (Parp1) 抗体
poly (ADP-ribose) polymerase family, member 1 (Parp1) 抗体
Poly-(ADP-ribose) polymerase (Parp) 抗体
poly(ADP-ribose) polymerase 1 L homeolog (parp1.L) 抗体
poly (ADP-ribose) polymerase 1 (PARP1) 抗体
poly(ADP-ribose) polymerase 1 (Parp1) 抗体
poly (ADP-ribose) polymerase 1 (parp1) 抗体
5830444G22Rik 抗体
Adprp 抗体
ADPRT 抗体
Adprt 抗体
ADPRT 1 抗体
ADPRT1 抗体
Adprt1 抗体
adprt1 抗体
AI893648 抗体
ARTD1 抗体
BEST:LD21673 抗体
C80510 抗体
CG17685 抗体
CG17696 抗体
CG17718 抗体
CG40411 抗体
D.PARP 抗体
Dm.pARTa 抗体
Dmel\\CG40411 抗体
dPARP 抗体
LD21673.3prime 抗体
pADPRT-1 抗体
padprt-1 抗体
PARP 抗体
parp 抗体
PARP-1 抗体
Parp-1 抗体
parp-1 抗体
PARP1 抗体
PPOL 抗体
ppol 抗体
si:dkey-206f10.3 抗体
sPARP-1 抗体
wu:fc60f12 抗体
zgc:110092 抗体
您还需要查找其他产品吗？
You are here:
